PedrolEGonzalez-ClementJMGatellJMMallolasJMiróJMGrausF. Central nervous system toxoplasmosis in AIDS patients: Efficacy of an intermittent maintenance therapy. AIDS1990; 4: 511–7.
2.
IsraelskiDMRemingtonJS. Toxoplasmic encephalitis in patients with AIDS. Infect Dis Clin North Am1988; 2: 429–43.
3.
RolstonKVIHoyJ. Role of clindamycin in the treatment of central nervous system toxoplasmosis. Am J Med1987; 83: 551–3.
4.
DannemannBRIsraelskiDMRemingtonJS. Treatment of toxoplasmic encephalitis with intravenous clindamycin. Arch Intern Med1988; 148: 2477–82.
5.
WestblomTUBelsheRB. Clindamycin therapy of cerebral toxoplasmosis in an AIDS patient. Scand J Infect Dis1988; 20: 561–3.
6.
LeportCBastuji-GarinSPerroneCSalmonDMarcheCBriçaireF. An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis (letter). J Infect Dis1989; 160: 557–8.
7.
WindholzM, ed. The Merck index. 11th ed.Rahway, NJ: Merck and Co., 1989: 1365.
8.
SneadOC. Minireview gammahydroxybutyrate. Life Sci1977; 20: 1935–44.
9.
MamelakM. Gammahydroxybutyrate: An endogenous regulator of energy metabolism. Neurosci Biobehav Rev1989; 13: 187–98.
10.
ReynoldsJEF, ed. Martindale: The extra pharmacopoeia. 29th ed.London: The Pharmaceutical Press, 1989: 1125.
11.
Centers for Disease Control. Multistate outbreak of poisonings associated with illicit use of gammahydroxybutyrate. JAMA1991; 265: 447–8.
12.
Gammahydroxybutyrate poisoning. Med Lett1991; 33: 8.
13.
ScharfMBFletcherKAJenningsSW. Current pharmacologic management of narcolepsy. Am Fam Physician1988; 38: 143–8.
14.
Narcolepsy. Signet/Mosby medical encyclopedia. New York: New American Library, 1987: 395.
15.
Association of Sleep Disorders Centers and the Association for the Psycho-physical Study of Sleep.Diagnostic classification of sleep and arousal disorders. Sleep1979; 2: 1–137.
16.
DementWCCarskadonMLeyR. The prevalence of narcolepsy (abstract). Sleep Res1973; 2: 147.
17.
ParkesJ. Amphetamines and alertness. In: GuilleminaultCDementWPassouantP, eds. Narcolepsy. New York: Spectrum, 1976: 643–58.
18.
MitlerMMShaforRHajdukovichRTimmsRMBrowmanCP. Treatment of narcolepsy: Objective studies on methylphenidate, pemoline, and protryptyline. Sleep1986; 9: 260–4.
19.
KalesASoldatosCRCadieuxRBixlerEOTanTLScharfMB. Propranolol in the treatment of narcolepsy. Ann Intern Med1979; 91: 741–3.
20.
Meier-EwertKMatsubayashiKBenterL. Propranolol: Long-term treatment in narcolepsy-cataplexy. Sleep1985; 8: 95–104.
21.
FryJMPressmanMRDiPhillipMAForst-PaulusM. Treatment of narcolepsy with codeine. Sleep1986; 9: 269–74.
22.
ScrimaLHartmanPGJohnsonFHJr.HillerFC. Efficacy of gammahydroxybutyrate versus placebo in treating narcolepsy-cataplexy: Double-blind subjective measures. Biol Psychiatry1989; 26: 331–43.
23.
TakahashiS. The action of tricyclics upon several symptoms of narcolepsy. In: GuilleminaultCDementWPassouantP, eds. Narcolepsy. New York: Spectrum, 1976: 303–10.
24.
ScrimaL. An etiology of narcolepsy-cataplexy and a proposed cataplexy neuromechanism. Int J Neurosci1981; 15: 69–86.
25.
ScharfMBFletcherKA. Rebound cataplexy: A complication of drug withdrawal in narcolepsy (abstract). Sleep Res1988; 17: 246.
26.
ScrimaLHartmanPGJohnsonFHJrThomasEEHillerFC. The effects of gammahydroxybutyrate on the sleep of narcolepsy patients: A double-blind study. Sleep1990; 13: 479–90.
27.
Zwyghuizen-DoorenbosARoehrsTSchaeferMRothT. Test-retest reliability of the MSLT. Sleep1988; 11: 562–5.
28.
AmiraSAJohnsonTSLogowitzNB. Diagnosis of narcolepsy using the multiple sleep latency test: Analysis of current laboratory criteria. Sleep1985; 8: 325–31.
29.
ScharfMBBrownDWoodsMBrownLHirschowitzJ. The effects and effectiveness of gammahydroxybutyrate in patients with narcolepsy. J Clin Psychiatry1985; 46: 222–5.
30.
MamelakMScharfMWoodsM. Treatment of narcolepsy with gammahydroxybutyrate: A review of clinical and sleep lab findings. Sleep1986; 9: 285–9.
31.
HausheerFHYarbroJW. Diagnosis and treatment of malignant pleural effusion. Semin Oncol1985; 12: 54–75.
32.
CardinaleV, ed. Drug topics red book 1991. Oradell, NJ: Medical Economics, 1991: 96, 163, 262.
33.
ManssonS. Treatment of malignant pleural effusion with doxycycline. Scand Infect Dis1988; 53S: 29–34.
34.
KitamuraSSugiyamaYIzumiTHayashiRKosakaK. Intrapleural doxycycline for control of malignant pleural effusion. Curr Ther Res1981; 30: 515–21.
35.
MuirJFDefouilloyCNdarurinzeSHermantAQuequetPMBroussierPM. The use of intra-pleural doxycycline by lavage and drainage in recurrent malignant pleural effusions. Rev Mal Respir1987; 4: 29–33.
36.
KitamuraSWagaiFIzumiTSugiyamaYKosakaK. Treatment of carcinomatous pericarditis with doxycycline: Intrapericardial doxycycline for control of malignant pericardial effusion. Curr Ther Res1981; 30: 589–96.
